Daewoong Pharmaceutical’s future plan to expand open innovation globally with Indonesia as a base in Southeast Asia was announced. CEO Jeon Seung-ho said, “We will expand Daewoong Pharmaceutical’s open innovation global with Indonesia as a base country in Southeast Asia.” .
Daewoong Pharmaceutical has set open innovation as a future core strategy for a long time and has been building a new cooperative model through investment in innovative startups and shared growth. Fields of particular attention are DDS formulation technology, cell and gene therapy, next-generation stem cell platform, neurotoxin, and artificial intelligence (AI).
Daewoong Pharmaceutical, invited to the ‘UI Investment & Start Up Forum’, an investment forum held at the University of Indonesia (UI) on the 14th, presented △R&D and open innovation direction △ Indonesia business and research status △ Future business plan in Indonesia. announced.
CEO Jeon Seung-ho introduced the Indonesian business and future plans that the company has been promoting, and shared the current status and plans of industry-university-linked open innovation to be promoted with excellent universities and talents.
About 300 people including government officials such as the Indonesian Ministry of Health and Welfare and the head of the Investment Coordination Agency, major academic figures such as the UI president, investors, and local media attended this forum. was composed There was also an opportunity to promote mutual cooperation by sharing business and investment strategies of major Indonesian pharmaceutical companies and investment companies.
UI, which hosted this event, is cooperating with Daewoong Pharmaceutical by establishing a bio-processing research institute and a bio-analysis laboratory in the university to share Daewoong Pharmaceutical’s research technology. We maintain mutual cooperation by conducting doctoral training programs, etc.
Professor Arry Yanuar, dean of UI College of Pharmacy, said, “Daewoong Pharmaceutical and UI, especially through cooperation with the College of Pharmacy, are planning more active activities in social contribution and industry-university connection fields as well as research fields.” “Daewoong Pharmaceutical and Indonesia We look forward to cooperation with the government for the development of R&D fields such as the establishment of a new formulation laboratory for UI and clinical laboratory projects,” he said.
